LAMELLASOME™ Anti-fibrotic Platform
Products disrupt the progression of fibrosis, the key pathology of progressive pulmonary fibrosis
LAMELLASOME™ Anti-infective Platform
Products are designed to tackle serious bacterial infection and the global crisis of antimicrobial resistance
LAMELLASOME™ Rare Disease Platform
Products advancing novel treatments for rare diseases where there is high unmet clinical need.